Abstract:Myostatin is a negative regulator of muscle mass that may contribute to the muscle wasting observed in response to traumatic injury. The purpose of this study was to determine whether muscle myostatin mRNA abundance was altered by different traumatic insults and whether the change in myostatin was associated with alterations in insulin‐like growth factor (IGF)‐I and IGF‐II mRNA in gastrocnemius, or the concentration of glucocorticoids in plasma. The abundance of myostatin mRNA was increased three‐ to fourfold in gastrocnemius 24 h after a 30% total body surface area burn injury. In contrast, neither the injection of endotoxin nor the induction of peritonitis significantly altered myostatin mRNA at the same time point. IGF‐I mRNA in muscle was decreased (40–60%) by all insults, whereas the abundance of IGF‐II mRNA was unaltered. The plasma concentration of corticosterone was increased approximately threefold after burn injury, was only transiently elevated after endotoxin, and was only mildly increased (25%) in septic rats at the time of sacrifice. Pretreatment with the type II glucocorticoid receptor antagonist RU486 prevented the increased myostatin mRNA and decreased muscle protein content after burn. A single injection of dexamethasone in naive control animals increased muscle myostatin mRNA by 60% and 2.7‐fold at 4 h and 24 h, respectively. In contrast, pretreatment of burn rats with tumor necrosis factor binding protein (TNFBP), which antagonizes the actions of this cytokine, failed to prevent the burn‐induced increase in myostatin mRNA or the loss of muscle protein. The results of this study indicate that thermal injury, but not endotoxin or sepsis, increases myostatin mRNA content. Moreover, the burn‐induced increase in myostatin appears to be largely mediated by the enhanced endogenous secretion of glucocorticoids and independent of changes in IGF‐I, IGF‐II, or TNF.

Progress on the Application of Ligand Receptor Binding Assays in Radiopharmaceuticals

Application of Radiolabeled Drugs in Absorption, Distribution,metabolism and Excretion Studies

Advances in receptor chromatography for drug discovery and drug-receptor interaction studies

Prospect of Study and Application on PET Receptor Imaging

Radioligand Saturation Binding for Quantitative Analysis of Ligand-Receptor Interactions

Radiolabelled Quinoline Derivaties for the PET Imaging of Peripheral Benzodiazepine Receptor

Biological Applications of Autoradiography: Present and Future

Clinical status and prospective of brain receptor imaging

Recent Advances in the Quantitative Determination of Protein Receptor–Ligand Interaction Kinetics

Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics

Study on Neuroreceptor Imaging with Radionuclide Tracing in Vivo

Progress of Scintillation Proximity Assay in Life Science

Recent Development on Peptide-Based Probes for Multifunctional Biomedical Imaging

Preface for the Special Issue on Analysis of Drug or Drug Targets by Molecular Imaging

Quantitative Analysis of Receptor Imaging

Recent Advances in Emerging Radiopharmaceuticals and the Challenges in Radiochemistry and Analytical Chemistry

Regulation of Myostatin by Glucocorticoids After Thermal Injury

Design and Application of Receptor-Targeted Fluorescent Probes Based on Small Molecular Fluorescent Dyes

In Situ and Label-Free Quantification of Membrane Protein–Ligand Interactions Using Optical Imaging Techniques: A Review

Qualitative and Quantitative Imaging of Alpha‐emitting Radiopharmaceuticals

Living science: Science as an activity of living beings.